Switching strategies for antipsychotic monotherapy in schizophrenia: a multi-center cohort study of aripiprazole
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology
Link
http://link.springer.com/content/pdf/10.1007/s00213-019-05352-7.pdf
Reference40 articles.
1. Burris KD, Molski TF, Xu C, Ryan E, Tottori K, Kikuchi T, Yocca FD, Molinoff PB (2002) Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors. J Pharmacol Exp Ther 302:381–389
2. Busner J, Targum SD (2007) The clinical global impressions scale: applying a research tool in clinical practice. Psychiatry (Edgmont) 4:28–37
3. Caqueo-Urízar A, Gutiérrez-Maldonado J, Miranda-Castillo C (2009) Quality of life in caregivers of patients with schizophrenia: a literature review. Health Qual Life Outcomes 7:84
4. Casey DE, Carson WH, Saha AR et al (2003) Switching patients to aripiprazole from other antipsychotic agents: a multicenter randomized study. Psychopharmacology 166:391–399
5. Cerovecki A, Musil R, Klimke A, Seemüller F, Haen E, Schennach R, Kühn KU, Volz HP, Riedel M (2013) Withdrawal symptoms and rebound syndromes associated with switching and discontinuing atypical antipsychotics: theoretical background and practical recommendations. CNS Drugs 27:545–572
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. 統合失調症の歩み― 精神分裂病から自己免疫性精神病へ―;Okayama Igakkai Zasshi (Journal of Okayama Medical Association);2023-08-01
2. Comparison between olanzapine and aripiprazole treatment for 104 weeks after hospital discharge in schizophrenia spectrum disorders: a multicenter retrospective cohort study in a real-world setting;Psychopharmacology;2023-07-17
3. Switching antipsychotics to partial dopamine D2-agonists in individuals affected by schizophrenia: a narrative review;International Journal of Psychiatry in Clinical Practice;2023-07-10
4. Can brexpiprazole be switched safely in patients with schizophrenia and dopamine supersensitivity psychosis? A retrospective analysis in a real-world clinical practice;Journal of Psychopharmacology;2023-07-03
5. EFFECT OF ARIPIPRAZOLE COMBINED WITH OLANZAPINE ON THE CLINICAL EFFICACY OF SCHIZOPHRENIA;FARMACIA;2022-06-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3